AMAG Pharmaceuticals Inc. today announced that William
Heiden, AMAG’s chief executive officer, will present at the 31st
Annual J.P. Morgan Healthcare Conference on Wednesday, January 9, 2013
at 8:30 am Pacific Time. The presentation will include a company
overview and business update.
A live webcast of the presentation will be accessible through the
Investors section of the company’s website at Online Pharmacy.
Following the conference, the webcast will be archived on the AMAG
Pharmaceuticals, Inc. website until February 9, 2013.
About AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. is a specialty pharmaceutical company that
manufactures and markets Feraheme® (ferumoxytol) Injection for
Intravenous (IV) use in the United States. Along with driving organic
growth of its lead product, AMAG intends to expand its portfolio with
additional commercial-stage specialty pharmaceuticals. The company is
seeking complementary products that leverage the company’s commercial
footprint and focus on hematology and oncology centers and hospital
infusion centers.
a place for your medical questions answered correctly. Please consult a doctor or a medical clinic before using any of the information present on this page. More often than not, we just do not have time or shy away from visiting a doctor than anything else that comes in the way of taking proper precautions and timely steps for some health related problems. We offer free medical information and medical help.You will find medical questions asked by people like you and answers to them.